CTRI/2010/091/000188招募中3 期
An Open Label, Balanced, Randomized, Controlled, Parallel Design Microarray based Gene Expression Profiling Study to Evaluate the molecular mechanisms regulated in Type 2 Diabetes patients subjected to the seven sequences of Pranayama and oral hypoglycemic drugs versus only oral hypoglycemic drugs.Acronym PRA
Patanjali Ayurved Ltd.Address: Plot no. D-38, Hardwar industrial area,Hardwar -249 4010 个研究点目标入组 28 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient with Established type 2 diabetes (duration 1-10 years), on oral hypoglycemic agents (like Metformin or Glibenclamide) willing to participate in the study; Between 18-60 years.
排除标准
- •Patient on insulin or patients with diabetic complications like neuropathy, retinopathy, nephropathy, diabetic foot, chronic ulcer and cardiovascular diseases
研究者
相似试验
已完成
不适用
bioequivalence study of Posaconazole 100 mg gastro-resistant tablets of Signature Phytochemical IndustriesCTRI/2022/06/043016Signature Phytochemical Industries23
招募中
Unknown
Effects of a Probiotic Supplement on Blood Sugar and Gut Health in Adults with Prediabetes, Diabetes, and Diabetes with ObesityCTRI/2024/07/070100Dr. Reddy’s Laboratories
进行中（未招募）
Unknown
Bioequivalence study of Cladribine 10 mg tablet in relapsing forms of multiple sclerosis patientsCTRI/2024/03/063701Invitro Research Solutions Private Limited
尚未招募
4 期
Clinical trial for comparing Safety and Efficacy of Bio-enhanced Rifampicin (Risorine) Capsule in Newly Diagnosed Pulmonary Tuberculosis in Adult PatientsCTRI/2017/04/008329Dr Randeep Guleria144
进行中（未招募）
不适用
An open label, comparative, randomised, balanced crossover trial comparing nasal fentanyl and oral transmucosal fentanyl (Actiq) in breakthrough pain in patients with cancer - NDEUCTR2006-002087-26-ITYCOMED (HEADQUARTER)115